CHICAGO – People in the late stages of cancer and other terminal illnesses are not only unharmed by discontinuing statins for cholesterol management, they may benefit, according to a study presented Friday by researchers at Duke Medicine representing a national research network. PRESS RELEASE
Binghamton University presents the Care Management Summit 2014: Achieving Excellence Thursday and Friday, May 22–23, 2014 The College of Community and Public Affairs (CCPA) at Binghamton University invites you to attend a professional networking summit that offers TRANSDISCIPLINARY CONVERSATIONS and ACTIVE LEARNING . . . For more information and to register, visit http://www2.binghamton.edu/ccpa/care-management-summit/
New Sojourn Scholar Leadership Award Opportunity This initiative of the Cambia Health Foundation seeks to identify, support, and foster the next generation of leaders in the field of Palliative Medicine. The Award provides mentorship, networking, and 2-years of salary support for a project in Palliative Care. The projects can be in any activity that promotes the field and generates work that can be disseminated including research, education, program development, and policy and advocacy. The Award seeks burgeoning leaders in the field in the disciplines of nursing and medicine. You can find
We are excited to share that PCRC's abstract, "Safety of Discontinuing Statins among Patients with Life Limiting Illness" has been accepted for oral presentation at the 8th World Research Congress of the European Association for Palliative Care (EAPC) June 2014 in Lleida, Spain!
Published on January 24, 2014 at NewsMedical Duke University and the University of Colorado schools of medicine have received a $10 million grant from the National Institute for Nursing Research (NINR), part of the National Institutes of Health, to continue the development of the Palliative Care Research Cooperative Group (PCRC) over the next five years. The consortium addresses national research priorities in palliative care and end-of-life by enhancing the quality and efficiency of research and educating doctors and patients about best practices. The goal is to promote research that leads to